Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients

Clinical trial NCT01031628 · TERMINATED

Trial details

NCT number: NCT01031628
Sponsor: Sarcoma Alliance for Research through Collaboration
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors

Start date: 2010-01-01
Primary completion: 2011-06-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.